ArticleAmerican journal of respiratory and critical care medicine2022
Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Open access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 25 citations in OpenAlex.
- Comparative study on mouse models of acute exacerbation of pulmonary fibrosis.Experimental and therapeutic medicine · 2026Article
- AURKA regulates HBV-induced hepatic stellate cell inflammation and liver fibrosis by modulating K48-linked ubiquitination and proteasomal degradation of TLR3.Journal of bioenergetics and biomembranes · 2026Article
- Genes, gut microbiome and lungs: untangling the web of idiopathic pulmonary fibrosis.ERJ open research · 2026Article
- Microbiome-innate immune crosstalk in acute exacerbation of idiopathic pulmonary fibrosis: an amplification framework.Frontiers in immunology · 2026Review
- Immunosenescence in Idiopathic Pulmonary Fibrosis.Journal of inflammation research · 2026Review
- A biomarker-guided framework for corticosteroid treatment stratification in acute exacerbation of idiopathic pulmonary fibrosis.Frontiers in pharmacology · 2026Article
- The Role of Viral and Bacterial Infections in the Etiology of Behçet's Disease.Journal of clinical laboratory analysis · 2026Review
- hAMSCs regulate EMT in the progression of experimental pulmonary fibrosis through delivering miR-181a-5p targeting TGFBR1.Stem cell research & therapy · 2025Article
- Current advancements in the mechanisms and animal models of acute exacerbation of pulmonary fibrosis: a systematic review.Frontiers in pharmacology · 2025Review
- Role of toll-like receptors in pulmonary immunity: mechanisms and therapeutic implications.Frontiers in immunology · 2025Review
- Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review.International journal of molecular sciences · 2024Review
- The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis.Frontiers in immunology · 2024Review
- Microbiome features in bronchoalveolar lavage fluid of patients with idiopathic inflammatory myopathy-related interstitial lung disease.Frontiers in medicine · 2024Article
- Persistent microbial infections and idiopathic pulmonary fibrosis - an insight intoFrontiers in cellular and infection microbiology · 2024Review
- Animal models of acute exacerbation of pulmonary fibrosis.Respiratory research · 2023Review
- Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis.Biomedicines · 2023Article
- Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers.International journal of molecular sciences · 2023Review
- Hotspots and Frontiers of Host Immune Response in Idiopathic Pulmonary Fibrosis: A Bibliometric and Scientific Visual Research from 2000 to 2022.Journal of immunology research · 2023Article
- Insights from Transcriptomics: CD163American journal of respiratory cell and molecular biology · 2022Review
- Identifying the Risk of Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Step Forward.American journal of respiratory and critical care medicine · 2022Article
Corrections and comments
- Commented on by
Authors and funding
18 authors at 9 institutions in 4 countries.
Aoife N McElroySchool of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland.
Rachele InvernizziNational Heart and Lung Institute, Imperial College London, London, United Kingdom.ORCID 0000-0002-6957-9626
Joanna W LaskowskaSchool of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland.
Andrew O'NeillSchool of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland.
Mohammad DoroudianDepartment of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.ORCID 0000-0002-2933-9898
Mohsen MoghoofeiInfectious Diseases Research Centre and.
Shayan MostafaeiDepartment of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Feng LiMRC Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Alexander A PrzybylskiMRC Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
David N O'DwyerDivision of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Andrew G BowieSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, and.
Padraic G FallonSchool of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland.
Toby M MaherNational Heart and Lung Institute, Imperial College London, London, United Kingdom.ORCID 0000-0001-7192-9149
Cory M HogaboamDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Philip L MolyneauxNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Nik HiraniMRC Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Michelle E ArmstrongSchool of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland.ORCID 0000-0001-7729-755X
Seamas C DonnellySchool of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland.ORCID 0000-0001-7145-1843
Trinity College Dublin · IEQueen's Medical Centre · GBRoyal Brompton Hospital · GBCedars-Sinai Medical Center · USEdinburgh Royal Infirmary · GBImperial College London · GBKermanshah University of Medical Sciences · IRKharazmi University · IRUniversity of Michigan · US
Funding
Innate DNA sensing in rapidly progressing IPFR01HL123899 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI HOGABOAM, CORY M · 2015 to 2018
$2.0MDepartment of Health CS-2013-13-017HSRD VA CDA 13-017Medical Research Council G0701740Medical Research Council MR/K015206/1NHLBI NIH HHS R01 HL123899Wellcome Trust
Abstract
PubMed holds no abstract for this paper.
Indexed as
Idiopathic Pulmonary FibrosisAnti-Bacterial AgentsAntiviral AgentsDisease ProgressionHumansRNA, Ribosomal, 16SToll-Like Receptor 3Anti-Bacterial AgentsAntiviral AgentsRNA, Ribosomal, 16STLR3 protein, humanToll-Like Receptor 3acute exacerbationsidiopathic pulmonary fibrosislung microbiomeTLR3 L412Fviral and bacterial coinfection
Identifiers
What Socratic holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.